Contents
Market Overview
Switzerland began its first adult-use pilot sales in 2023 and now operates seven active projects, allowing enrolled participants to legally purchase cannabis under controlled conditions. Early findings indicate efficient operations, no notable public-order issues, and positive health-system integration signals.
Aggregate 2025 pilot sales are estimated at €XXX (refer to Prohibition Partners’ market sizing). In parallel, Switzerland advanced toward full commercial legalisation in 2025, positioning the country to potentially launch Europe’s first nationwide adult-use market in 2026.
Legislative Track to Full Legalisation (2025 → 2026)
Process & Timing: An explanatory report precedes a summer consultation; if passed, implementation is expected in 2026—creating Europe’s first fully commercial adult-use regime.
February 2025: The National Council’s Social Security & Health Committee backed a preliminary draft bill to legalise adult-use cannabis, permitting adults to grow, buy, possess, and consume.
Model: State-monopoly retail via a limited number of licensed outlets; THC-based taxation differentiated by form of consumption; revenues earmarked for redistribution via health insurance.
Home Grow: Up to three female plants per adult. Possession thresholds to be finalised.
Cantonal Role: Cantons retain significant oversight on implementation.
Pilot Projects Framework (since 2021)
- Legal basis enables scientific pilot trials to assess impacts of regulated sales on consumer behaviour, public health, youth protection, illicit markets, and public safety.
- Seven trials active; up to 5,000 participants per trial; ~10,000 active buyers across projects.
- Purchase caps: 10 g THC/month (equivalent to 50–100 g flower, depending on potency).
- All trials run by public institutions (universities, research institutes, municipalities, foundations).
Pilot Projects: Profiles, Products, Interim Results
Weed Care(Basel-Stadt)
- Max participants: 378 | Active: 299 (Mar 2025)
- Sales start: 30 Jan 2023 | End: Jan 2027
- Organisers: Health Dept. Basel-Stadt; UPK Basel; PD-AG; University of Basel
- Focus: Compare pharmacy-based regulated sales vs illegal sourcing; extension assesses outcome changes when legal access ceases.
Products & Prices (producer: Pure Holding AG)
| Strain / Format | THC | CBD | Price (CHF/g) |
|---|---|---|---|
| Girl Scout Cookies (Flower) | 20% | <1% | 11.00 |
| Amnesia Passion (Flower) | 12% | <1% | 10.00 |
| Green Mango (Flower) | 8% | 8% | 9.00 |
| Lemon Diesel (Flower) | 6% | 12% | 8.00 |
| Diesel Pollen (Hash) | 20% | 5% | 12.00 |
| Lemon Resin (Hash) | 15% | 5% | 11.00 |
| Vape High THC (Vape) | 20% | 5% | 30.00 |
| Vape Balanced (Vape) | 10% | 10% | 25.00 |
| Oil 10 ml (Oil) | 18% | <1% | 65.00 |
| Spray 10 ml (Spray) | 5% | 5% | 55.00 |
Interim Results (Mar 2025)
- 87 kg sold; ~CHF 900k shifted from illicit market.
- ⅓ of purchases <13% THC; no increase in purchase volume or consumption.
- 89% join to support regulation; 84% value higher product quality; 79% cite safer access.
Züri Can (Zürich)
- Max: 3,000 | Active: 2,232 (Apr 2025)
- Sales start: 22 Aug 2023 | End: Oct 2026
- Organisers: City & University of Zürich
- Focus: Health and consumption effects; multi-channel distribution (10 pharmacies, 10 cannabis social clubs, 1 Drug Info Centre).
Products & Prices (Pure Production AG; SwissExtract)
| Product | Format | THC | CBD | Price (CHF/g) | Producer |
|---|---|---|---|---|---|
| Sour Pollen | Hash | 20% | 5% | 9.80 | Pure Production |
| Jura Gold | Hash | 20% | 5% | 9.80 | SwissExtract |
| Grand Marais | Hash | 15% | 10% | 8.80 | SwissExtract |
| Wedding Cake | Flower | 20% | 0% | 9.80 | SwissExtract |
| Blue Dream | Flower | 18% | 0% | 9.60 | Pure Production |
| Super Lemon Haze | Flower | 15% | 0% | 9.30 | Pure Production |
| Cleopatra’s Milk | Flower | 14.5% | 0% | 9.30 | SwissExtract |
| Cherry Valley Cake | Flower | 14% | 0% | 9.20 | SwissExtract |
| Cairo Dessert | Flower | 12% | 0% | 9.00 | SwissExtract |
| Apricot Mimosa | Flower | 9% | 8% | 7.90 | SwissExtract |
Interim Results (Apr 2025)
- ~150 dropouts (survey lapses/cessation of use).
- Demographics: 80% male; 18.7% female; 1.3% non-binary; avg age ~35 (largest 28–32 y/o cohort).
- Use frequency: 55.8% ≥4×/week; 28.3% 2–3×/week.
- High satisfaction with product quality and prevention/counselling materials.
Grashaus Projects (Basel-Landschaft)
- Max: 3,950 | Active: >1,000 (Aug 2024)
- Sales start: 7 Dec 2023 | End: Oct 2028
- Organisers: ISGF; Sanity Group Switzerland AG
- Focus: Specialty-store sales with trained staff; measure harm reduction and shift from illicit market.
Products & Prices (SwissExtract; 5-g packs)
| Name | Format | THC | CBD |
|---|---|---|---|
| Cherry Valley Cake | Flower | 17% | <1% |
| Wedding Cake | Flower | 20% | <1% |
| JBT Kush | Flower | 20% | <1% |
| Cleopatra’s Milk | Flower | 18% | <1% |
| Mother’s Choice | Flower | 17% | <1% |
| Alpenglow | Flower | 15% | <1% |
| Friesland | Flower | 14% | <1% |
| Cairo Dessert | Flower | 12% | <1% |
| Apricot Mimosa | Flower | 9% | 8% |
| Ciskei | Flower | 5% | 8% |
Interim Results (12-month)
- ~⅔ of participants purchase almost exclusively in licensed stores (reduced illicit reliance).
- Shift toward lower-risk forms (edibles, oral solutions, vapes).
- Low dropout; high satisfaction and research motivation.
Cann-L (Lausanne)
- Max: 1,600 | Active: 1,396 (Mar 2025)
- Sales start: 11 Dec 2023 | End: Summer 2027
- Organisers: City of Lausanne; Addiction Suisse
- Focus: Non-profit retail model; strong advice & health objectives.
Products & Prices (secret 10,000 m² site; flowers)
| Name | THC | Price (CHF/g) |
|---|---|---|
| Alpha | <5% | 9–12 |
| Beta | 5–10% | 9–12 |
| Gamma | 10–15% | 9–12 |
| Delta | 15% | 9–12 |
Year-1 Results (Dec 2024)
- >10 kg sold in Nov 2024 (~15% of Lausanne’s monthly consumption; ~CHF 1m equivalent).
- Participants: 18–80 y/o (avg 37); 77% male; 67% employed.
- Stable consumption; >25% of flower sales <10% THC; 38 participants sought medical advice.
La Cannabinothèque (Vernier, Geneva)
- Max: 1,200 | Active: 1,100 (Dec 2024)
- Sales start: 11 Dec 2023 | End: Jun 2027
- Organisers: University of Geneva (IRS); HUG; Association ChanGE; Municipality of Vernier; FEGPAC
- Focus: Effects of regulated access on knowledge, risk reduction, and neighbourhood impact.
Products & Prices
- Range of flowers, one hash, one oil; CHF 9–12/g (3-g packs); varied THC/CBD.
- Cultivated at a 10,000 m² greenhouse (French-speaking region).
Year-1 Findings (Dec 2024)
- Participants 18–80 y/o; ~80% male.
- ⅓ under 30; ½ between 30–50; 20% over 50.
- Unexpectedly high demand for low-THC products (min 4% offered).
SCRIPT (Bern, Biel & Lucerne)
- Max: 1,091 | Active: 1,091 (Mar 2025)
- Sales start: Apr 2024 (Bern); Jun 2024 (Biel & Lucerne) | End: Apr 2026
- Organisers: University of Bern (BIHAM, CTU, ISPM, UPD); University of Lucerne (Zentrum für Hausarztmedizin und Community Care)
- Funders: SNSF; Tobacco Control Fund; cities
- Focus: Effects of pharmacy-based sales on consumption & health; tobacco co-use.
Products (Pure Production AG)
- Four flowers; two hash; two tincture sprays; two e-liquids (prices undisclosed; proceeds cost-cover the experiment).
Early Snapshot
- Bern registrations: ~80% men; 18% women; 2% non-binary.
Cannabis Research Zürich (Canton of Zürich)
- Max: 7,500 (A 2,500 / B 2,500 / C 2,500 no-access control) | Active: 3,900 (Dec 2024)
- Sales start: 2 May 2024 | End: Dec 2028
- Organisers: ETH Zürich (KOF); University of Zürich (Economics) | Funder: Swiss Cannabis Research Association
- Focus: RCT on social & economic impacts; self-regulation programme; sales via 3 specialty stores + 8 pharmacies.
Products & Prices (SwissExtract; Alpina Pharma; Charlie’s Lab)
| Product | Format | THC | CBD | Price |
|---|---|---|---|---|
| Wedding Cake | Flower | 20% | <1% | CHF 12/g |
| Amnesia Haze | Flower | 20% | <1% | CHF 12/g |
| Royal Feast | Flower | 15% | <1% | CHF 11/g |
| Bubba Kush | Flower | 15% | <1% | CHF 11/g |
| Apricot Mimosa | Flower | 9% | 8% | CHF 8/g |
| Ciskie | Flower | 5% | 7.5% | CHF 7/g |
| Grand Marias | Hash | 15% | 10% | CHF 10/g |
| Jura Gold | Hash | 20% | <5% | CHF 12/g |
| Fumo D’Oro | Vape | 20% | <2% | CHF 40/ml |
| Fumo D’Oro Balanced | Vape | 20% | 20% | CHF 41/ml |
Results: Limited public data to date; interim analyses pending.
Pipeline Projects (Ticino & Others)
- Multiple applications reportedly under review by the FOPH; two confirmed submissions in Ticino (incl. “Cannabis in Ticino” with University of St. Gallen & Areté Solutions).
- March 2025: Ticino Grand Council declined to take supportive action; however, cantonal opposition does not automatically block FOPH approval. Federal decisions are pending.
Market Outlook
Switzerland’s pilot programme is generating robust, multi-site evidence on regulated access, with early signals of illicit-market displacement, demand for lower-THC options, and no measurable escalation in consumption among participants.
With pre-legislative approval secured and consultations scheduled, Switzerland is on a credible path to launch a national, state-monopoly retail model in 2026, likely becoming Europe’s first fully commercial adult-use market. Results from the pilots will directly inform product standards, retail design, taxation, and public-health safeguards in the final law.
